A leader in regenerative medicine, International Stem Cell Corp. uses its parthenogenesis stem cell technology to address immune rejection and self-renewing cells. This technology uses unfertilized eggs that have cells with a duplicate set of human leukocyte antigen genes (HLA) that lessen the chance of a body rejecting cells. From this, scientists created self-renewing human parthenogenetic neural stem cells (hpNSC).
These cells have the capacity to replace dead and dying neurons while protecting existing ones in patients with Parkinson’s disease. In fact, the company recently presented its preclinical results for the treatment of the disease at Neuroscience in Chicago. Furthermore, scientists with the company are currently developing cell technology to treat liver and retinal diseases.
The International Stem Cell Corp. also has a hand in anti-aging skin care products that uses its stem cell technology through its subsidiary Lifeline Skin Care. This technology is based on the communication between human cells. Protein molecules can carry messages that tell the surrounding cells to create new cells for tissue repair. The company removes those proteins from the parthenogenetic stem cells then creates microscopic bubbles called nanospheres to protect them from exposure. These tiny bubbles are then infused with vitamins, minerals, moisturizers, and antioxidants to create a finished serum.
Lifeline Skin Care has a range of products that include overnight, daily, neck and eye firming, and cleanser creams that can improve the look and feel of skin.
The innovative stem cell based technology of the company is not limited to degenerative diseases of the body. Skin can also benefit from parthenogenesis through the addition of healthy cells that prevent the look of aging though rejuvenation. Proceeds from the skin care line help support research for Parkinson’s, liver, and blindness diseases.
For more information on International Stem Cell Corporation visit www.internationalstemcell.com
Let us hear your thoughts: International Stem Cell Corp. Message Board
